help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LAGHI, F.
Right arrow Articles by TOBIN, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LAGHI, F.
Right arrow Articles by TOBIN, M. J.

Am. J. Respir. Crit. Care Med., Volume 160, Number 6, December 1999, 1916-1921

Does Inhaled Albuterol Improve Diaphragmatic Contractility in Patients with Chronic Obstructive Pulmonary Disease?

UMUR Ş. HATIPOĞLU, FRANCO LAGHI, and MARTIN J. TOBIN

The Division of Pulmonary and Critical Care Medicine, Edward Hines Jr. Veterans Administration Hospital, and Loyola University of Chicago Stritch School of Medicine, Hines, Illinois

We tested the hypothesis that the decrease in dyspnea in patients with COPD with inhaled albuterol is in part due to increased diaphragmatic contractility. Eleven patients with COPD inhaled albuterol or placebo in a double-blind randomized manner. Subsequently, dyspnea was measured while patients breathed through inspiratory resistors, and diaphragmatic contractility was quantified during maximal inspiratory efforts and after twitch stimulation of the phrenic nerves. Albuterol produced a decrease in dyspnea (5 ± 2 to 4 ± 2 [SD] Borg units, p < 0.01), and increases in maximal transdiaphragmatic pressure (92.4 ± 37.2 to 102.8 ± 37.2 cm H2O, p < 0.03) and potentiated twitch transdiaphragmatic pressures (21.6 ± 7.1 to 25.2 ± 7.6 cm H2O, p < 0.02). The decrease in dyspnea correlated with the increases in maximal and twitch transdiaphragmatic pressures: r = -0.64 (p = 0.04) and r = -0.65 (p = 0.04), respectively. Compared with placebo, albuterol produced an increase in inspiratory capacity (1.87 ± 0.71 to 2.26 ± 0.74 L, p = 0.002), which accounted for the increases in maximal and twitch transdiaphragmatic pressures. The decrease in dyspnea correlated with the increase in inspiratory capacity (r = -0.62, p = 0.04), but not with the increase in FEV1 (r = -0.13, p = 0.72). In conclusion, albuterol relieves dyspnea and enhances respiratory muscle output in patients with COPD primarily by improving the length-tension relationship of the diaphragm rather than by improving its contractility.




This article has been cited by other articles:


Home page
 ChestHome page
M. Licker, J.-M. Tschopp, J. Robert, J.-G. Frey, J. Diaper, and C. Ellenberger
Aerosolized Salbutamol Accelerates the Resolution of Pulmonary Edema After Lung Resection
Chest, April 1, 2008; 133(4): 845 - 852.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
N. Roche
Where current pharmacological therapies fall short in COPD: symptom control is not enough
Eur. Respir. Rev., September 1, 2007; 16(105): 98 - 104.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. F. Gelb, C. F. Taylor, P. A. McClean, C. M. Shinar, M. T. Rodrigues, C. A. Gutierrez, K. R. Chapman, and N. Zamel
Tiotropium and Simplified Detection of Dynamic Hyperinflation
Chest, March 1, 2007; 131(3): 690 - 695.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. F. Gelb, C. A. Gutierrez, I. M. Weisman, R. Newsom, C. F. Taylor, and N. Zamel
Simplified Detection of Dynamic Hyperinflation
Chest, December 1, 2004; 126(6): 1855 - 1860.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
W.D-C. Man, J. Moxham, and M.I. Polkey
Magnetic stimulation for the measurement of respiratory and skeletal muscle function
Eur. Respir. J., November 1, 2004; 24(5): 846 - 860.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. L. Croxton, G. G. Weinmann, R. M. Senior, R. A. Wise, J. D. Crapo, and A. S. Buist
Clinical Research in Chronic Obstructive Pulmonary Disease: Needs and Opportunities
Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1142 - 1149.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. Di Marco, J. Milic-Emili, B. Boveri, P. Carlucci, P. Santus, F. Casanova, M. Cazzola, and S. Centanni
Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD
Eur. Respir. J., January 1, 2003; 21(1): 86 - 94.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S E Cattapan, F Laghi, and M J Tobin
Can diaphragmatic contractility be assessed by airway twitch pressure in mechanically ventilated patients?
Thorax, January 1, 2003; 58(1): 58 - 62.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. F. Newton, D. E. O'Donnell, and L. Forkert
Response of Lung Volumes to Inhaled Salbutamol in a Large Population of Patients With Severe Hyperinflation*
Chest, April 1, 2002; 121(4): 1042 - 1050.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
I. M. Stell, M. I. Polkey, P. J. Rees, M. Green, and J. Moxham
Inspiratory Muscle Strength in Acute Asthma
Chest, September 1, 2001; 120(3): 757 - 764.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. SINDERBY, J. SPAHIJA, and J. BECK
Changes in Respiratory Effort Sensation Over Time Are Linked to the Frequency Content of Diaphragm Electrical Activity
Am. J. Respir. Crit. Care Med., March 15, 2001; 163(4): 905 - 910.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society 		  Red Transition